Floatz logo

Xifaxan

Chronic Abdominal Pain

Children's Hospital Los AngelesN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Abdominal Pain cohort.

Asset / SponsorPhaseRating
Lacosamide
Indiana University
Phase 1CC

Same molecule, other indications

Xifaxan is also rated in:

primary sclerosing cholangitisDormant
CC
Indicative ·
46 / 100
View asset →
small intestinal bacterial overgrowthDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →